Flaherty will remain with the Tigers after electing not to opt out of his $20 million contract for 2026, Jeff Passan of ESPN.com reports.

Flaherty surely could have received more guaranteed money on the open market, but he has decided to stay put following an up-and-down 2025 campaign. The right-hander posted a 4.64 ERA across 31 regular-season starts for the Tigers, but he also fanned 188 batters over 161 innings. Staying put at Comerica Park and having what should be an above-average offense to support him help Flaherty's case for 2026.

Twins president of baseball operations Derek Falvey said Tuesday that Festa (shoulder) should resume throwing relatively soon, Aaron Gleeman of The Athletic reports.

Festa was diagnosed with thoracic outlet syndrome in September, but it's considered a mild version and he was given Botox injections to alleviate a compressed nerve between his right shoulder and neck. A setback is possible, but for now Festa is expected to be ready for the start of spring training. If healthy, the young righty will compete for a spot in the Twins' rotation next season. Festa held a 5.40 ERA, 1.28 WHIP and 53:19 K:BB over 53.1 innings in 2025 with the big club.

Twins president of baseball operations Derek Falvey said Tuesday that Lopez (forearm) is fully healthy and projected to have a normal offseason, Aaron Gleeman of The Athletic reports.

Lopez's 2025 season ended in late September with a mild right forearm strain, and he also missed two months earlier in the year with a Grade 2 teres major strain. However, there are no current concerns with Lopez's pitching arm entering the offseason, and he will not face restrictions at the beginning of spring training. The 29-year-old pitched well in 2025 when healthy, posting a 2.74 ERA and 73:20 K:BB over 75.2 innings. Lopez is owed $43.5 million over the next two seasons, and with the Twins shedding payroll, he's a trade candidate this winter.

The Brewers declined Quintana's $15 million mutual option for 2026 on Tuesday.

The veteran left-hander will be given a $2 million buyout instead. Quintana made 24 regular-season starts for the Brewers this season, finishing with a 3.96 ERA, 1.29 WHIP and 89:50 K:BB over 131.2 frames. The southpaw will turn 37 in January but should be able to land a decent contract from a club in need of a back-end starter.

The Brewers declined Contreras' $12 million option for 2026.

Contreras will receive a $100,000 buyout instead, and he remains under team control for 2026 and 2027 as an arbitration-eligible player. The catcher slashed .260/.355/.399 with 17 home runs over 150 regular-season games for the Brewers in 2025. Contreras was scheduled to visit a hand specialist last week to determine whether he needs surgery to repair a fractured left middle finger, but there's no word on whether an operation is required. Even if he does have surgery, his availability for spring training is not expected to be in peril.

Story will remain with the Red Sox after choosing not to opt out of the two years and $50 million left on his contract, Chris Cotillo of MassLive.com reports.

Story is owed $25 million each of the next two seasons and the Red Sox have a $25 million club option or $5 million buyout on him for 2028. He might have been able to get more than that on the open market, but Story -- who will turn 33 later this month -- has opted to stay put. Story slashed .263/.308/.433 with 25 home runs and 31 stolen bases over 157 regular-season games for Boston in 2025.

The Royals placed Wright on outright waivers Tuesday, Jon Heyman of the New York Post reports.

Wright didn't pitch at all in 2024 and made only eight rehab starts in 2025 due to right shoulder surgery and more recently an oblique strain. He's considered healthy now, but Wright's velocity was down and he posted a 5.48 ERA in his 23 innings between Double-A Northwest Arkansas and Triple-A Omaha this season. The former 20-game winner turned 30 last month and might have to settle for a minor-league contract this offseason.

Darvish will miss the 2026 season following a right elbow UCL repair with an internal brace and flexor tendon surgery on Oct. 29.

Darvish has missed time each of the last three seasons with elbow issues, having been limited to 72 regular-season innings in 2025. It's unclear how long he's been pitching with UCL damage, but the decision was finally made to have surgery on the elbow. It's the second UCL repair for Darvish, who had Tommy John surgery in March 2015. Darvish turned 39 in August, but he intends to rehab and return to the Padres for the 2027 season.

The Tigers declined Dobnak's $6 million option for 2026, Evan Petzold of the Detroit Free Press reports.

He'll be given a $1 million buyout instead. Dobnak's inclusion in the deadline trade that also sent Chris Paddack from the Twins to the Tigers was a way for Minnesota to offload additional salary. The 30-year-old is now a free agent after spending nearly all of 2025 at the Triple-A level, where he posted a 5.84 ERA over 18 starts and eight relief appearances.

The Rockies declined Farmer's $4 million mutual option for 2026 on Tuesday, Thomas Harding of MLB.com reports.

The club will pay him a $750,000 buyout instead. Farmer slashed just .227/.280/.365 with eight home runs over 97 contests for the Rockies this season. The utility infielder is now a free agent.